Australia - English - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd - brimonidine tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd - brimonidine tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd - brimonidine tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - brimonidine tartrate, quantity: 1.5 mg/ml - eye drops, solution - excipient ingredients: magnesium chloride hexahydrate; boric acid; sodium chlorite; sodium chloride; carmellose sodium; borax; sodium hydroxide; purified water; hydrochloric acid; potassium chloride; calcium chloride dihydrate - alphagan p 1.5 eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan p 1.5 eye drops can be used in the treatment of glaucoma as either monotherapy or in combination with topical beta blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: polyvinyl alcohol; benzalkonium chloride; citric acid; hydrochloric acid; sodium citrate dihydrate; sodium chloride; sodium hydroxide; purified water - indications:enidin eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: enidin eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension.enidin eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; purified water; sodium chloride; polyvinyl alcohol; citric acid; benzalkonium chloride; hydrochloric acid; sodium citrate dihydrate - indications: alphagan eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: alphagan eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - lodoxamide trometamol -

New Zealand - English - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - levobunolol hydrochloride 0.25%{relative};  ;  ;   - eye drops, solution - 0.25 % - active: levobunolol hydrochloride 0.25%{relative}       excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate hydrochloric acid monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - levobunolol hydrochloride 0.5%{relative};  ;  ;   - eye drops, solution - 0.5 % - active: levobunolol hydrochloride 0.5%{relative}       excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate hydrochloric acid monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - apraclonidine hydrochloride 5.75 mg/ml equivalent to 5 mg apraclonidine - eye drops, solution - 0.5 % - active: apraclonidine hydrochloride 5.75 mg/ml equivalent to 5 mg apraclonidine excipient: benzalkonium chloride hydrochloric acid purified water sodium acetate trihydrate sodium chloride sodium hydroxide - iopidine eye drops 0.5% are indicated for short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional intraocular pressure reduction. patients on maximally tolerated medical therapy who are treated with iopidine eye drops 0.5% to delay surgery should have frequent follow up examinations and treatment should be discontinued if the intraocular pressure rises significantly.